SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

NewcelX Ltd. (NCEL) News

Follow NewcelX Ltd. (NCEL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol NCEL Asset equity Sector Markets 90 days 1 Last 2.67 Updated Nov 04, 2026, 01:11 PM UTC Open live news feed Open NCEL chart & news
L NewcelX Agrees to Sell Mazindol Portfolio to REA Holdings NewcelX entered a binding term sheet to sell its Mazindol portfolio to REA Holdings. MNA | Nov 04, 2026, 01:11 PM UTC L RCL completes $1.25 billion senior unsecured notes offering RCL completes its offering of $1.25 billion senior unsecured notes due 2034; the wire also lists secondary-stock offering and registration items for AVAH, BKV, NCEL and PYXS. RATES | Aug 21, 2026, 10:59 AM UTC H NCEL Prices $1.4M Equity Financing NCEL prices equity financing at 20% premium EQUITY | Jul 31, 2026, 01:00 PM UTC L NewcelX Completes Type B Pre-IND Meeting With FDA; Administration Provided Constructive Feedback And Alignment On Proposed Strategy The FDA provided clarity regarding the regulatory pathway toward launching a clinical trial of NCEL-101 for type 1 diabetes in combination with Eledon Pharmaceuticals’ (NASDAQ: ELDN ) anti-CD40L antibody, tegoprubart, an REGULATION | Jul 01, 2026, 01:33 PM UTC